Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Allogene Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ALLO
Nasdaq
8731
https://allogene.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Allogene Therapeutics Inc
Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag
- May 14th, 2024 4:56 pm
Allogene Therapeutics Inc (ALLO) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
- May 14th, 2024 7:06 am
Allogene Therapeutics (ALLO) Reports Q1 Loss, Lags Revenue Estimates
- May 13th, 2024 9:10 pm
Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock
- May 13th, 2024 8:47 pm
Allogene Therapeutics Reports First Quarter 2024 Financial ResultsĀ and Business Update
- May 13th, 2024 8:01 pm
CollPlant Biotechnologies (CLGN) Soars 8.2%: Is Further Upside Left in the Stock?
- May 10th, 2024 1:51 pm
Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update
- May 6th, 2024 12:30 pm
Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma
- Apr 26th, 2024 12:30 pm
Omega Therapeutics, Inc. (OMGA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
- Apr 25th, 2024 2:02 pm
Allogene Therapeutics (ALLO) Expected to Beat Earnings Estimates: Should You Buy?
- Apr 24th, 2024 2:01 pm
3 Meme Stocks to Sell and Replace With Meme Coins
- Apr 11th, 2024 6:45 pm
Allogene Therapeutics Announces Q2 Investor Conference Participation
- Apr 9th, 2024 12:30 pm
How Allogene (ALLO) Stock Stands Out in a Strong Industry
- Apr 8th, 2024 12:46 pm
We Think Allogene Therapeutics (NASDAQ:ALLO) Needs To Drive Business Growth Carefully
- Apr 7th, 2024 2:22 pm
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2023 Earnings Call Transcript
- Mar 16th, 2024 8:35 pm
Allogene's (ALLO) Q4 Loss Narrower Than Expected, Sales Miss
- Mar 15th, 2024 1:32 pm
Q4 2023 Allogene Therapeutics Inc Earnings Call
- Mar 15th, 2024 11:04 am
Allogene Therapeutics Inc (ALLO) Reports Q4 and Full Year 2023 Financials, Forecasts Cash ...
- Mar 14th, 2024 9:34 pm
Allogene Therapeutics (ALLO) Reports Q4 Loss, Lags Revenue Estimates
- Mar 14th, 2024 9:15 pm
Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update
- Mar 14th, 2024 8:05 pm
Scroll